Literature DB >> 34333707

Muscularity Defined by the Combination of Muscle Quantity and Quality is Closely Related to Both Liver Hypertrophy and Postoperative Outcomes Following Portal Vein Embolization in Cancer Patients.

Siyuan Yao1, Naoko Kamo2, Kojiro Taura2, Yosuke Miyachi2,3, Sena Iwamura2, Masaaki Hirata2, Toshimi Kaido3, Shinji Uemoto2,4.   

Abstract

BACKGROUND: Portal vein embolization (PVE) is a common procedure for preventing hepatic insufficiency after major hepatectomy. While evaluating the body composition of surgical patients is common, the impact of muscularity defined by both muscle quantity and quality on liver hypertrophy after PVE and associated outcomes after major hepatectomy in patients with hepatobiliary cancer remain unclear.
METHODS: This retrospective review included 126 patients who had undergone hepatobiliary cancer resection after PVE. Muscularity was measured on preoperative computed tomography images by combining the skeletal mass index and intramuscular adipose content. Various factors including the degree of hypertrophy (DH) of the future liver remnant and post-hepatectomy outcomes were compared according to muscularity.
RESULTS: DH did not differ by malignancy type. Patients with high muscularity had better DH after PVE (P = 0.028), and low muscularity was an independent predictor for poor liver hypertrophy after PVE [odds ratio (OR), 3.418; 95% confidence interval (CI), 1.129-10.352; P = 0.030]. In subgroup analyses in which patients were stratified into groups based on primary hepatobiliary tumors and metastases, low muscularity was associated with higher incidence of post-hepatectomy liver failure (PHLF) ≥ grade B (P = 0.018) and was identified as an independent predictor for high-grade PHLF (OR 3.931; 95% CI 1.113-13.885; P = 0.034) among the primary tumor group. In contrast, muscularity did not affect surgical outcomes in patients with metastases.
CONCLUSIONS: Low muscularity leads to poor liver hypertrophy after PVE and is also a predictor of PHLF, particularly in primary hepatobiliary cancer.
© 2021. Society of Surgical Oncology.

Entities:  

Mesh:

Year:  2021        PMID: 34333707     DOI: 10.1245/s10434-021-10525-w

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  42 in total

1.  Portal vein embolization before major hepatectomy and its effects on regeneration, resectability and outcome.

Authors:  D Ribero; E K Abdalla; D C Madoff; M Donadon; E M Loyer; J-N Vauthey
Journal:  Br J Surg       Date:  2007-11       Impact factor: 6.939

2.  Impact of preoperative quality as well as quantity of skeletal muscle on survival after resection of pancreatic cancer.

Authors:  Shinya Okumura; Toshimi Kaido; Yuhei Hamaguchi; Yasuhiro Fujimoto; Toshihiko Masui; Masaki Mizumoto; Ahmed Hammad; Akira Mori; Kyoichi Takaori; Shinji Uemoto
Journal:  Surgery       Date:  2015-03-19       Impact factor: 3.982

3.  Preoperative portal vein embolization for hepatocellular carcinoma.

Authors:  H Kinoshita; K Sakai; K Hirohashi; S Igawa; O Yamasaki; S Kubo
Journal:  World J Surg       Date:  1986-10       Impact factor: 3.352

4.  Impact of Skeletal Muscle Mass Index, Intramuscular Adipose Tissue Content, and Visceral to Subcutaneous Adipose Tissue Area Ratio on Early Mortality of Living Donor Liver Transplantation.

Authors:  Yuhei Hamaguchi; Toshimi Kaido; Shinya Okumura; Atsushi Kobayashi; Hisaya Shirai; Shintaro Yagi; Naoko Kamo; Hideaki Okajima; Shinji Uemoto
Journal:  Transplantation       Date:  2017-03       Impact factor: 4.939

5.  Body composition and outcome in patients undergoing resection of colorectal liver metastases.

Authors:  M G van Vledder; S Levolger; N Ayez; C Verhoef; T C K Tran; J N M Ijzermans
Journal:  Br J Surg       Date:  2012-01-13       Impact factor: 6.939

6.  Preoperative intramuscular adipose tissue content is a novel prognostic predictor after hepatectomy for hepatocellular carcinoma.

Authors:  Yuhei Hamaguchi; Toshimi Kaido; Shinya Okumura; Takashi Ito; Yasuhiro Fujimoto; Kohei Ogawa; Akira Mori; Ahmed Hammad; Etsuro Hatano; Shinji Uemoto
Journal:  J Hepatobiliary Pancreat Sci       Date:  2015-03-05       Impact factor: 7.027

7.  Impact of Visceral Adiposity as Well as Sarcopenic Factors on Outcomes in Patients Undergoing Liver Resection for Colorectal Liver Metastases.

Authors:  Atsushi Kobayashi; Toshimi Kaido; Yuhei Hamaguchi; Shinya Okumura; Hisaya Shirai; Naoko Kamo; Shintaro Yagi; Kojiro Taura; Hideaki Okajima; Shinji Uemoto
Journal:  World J Surg       Date:  2018-04       Impact factor: 3.352

8.  Impact of quality as well as quantity of skeletal muscle on outcomes after liver transplantation.

Authors:  Yuhei Hamaguchi; Toshimi Kaido; Shinya Okumura; Yasuhiro Fujimoto; Kohei Ogawa; Akira Mori; Ahmed Hammad; Yumiko Tamai; Nobuya Inagaki; Shinji Uemoto
Journal:  Liver Transpl       Date:  2014-11       Impact factor: 5.799

9.  Two hundred forty consecutive portal vein embolizations before extended hepatectomy for biliary cancer: surgical outcome and long-term follow-up.

Authors:  Masato Nagino; Junichi Kamiya; Hideki Nishio; Tomoki Ebata; Toshiyuki Arai; Yuji Nimura
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

10.  Sarcopenia as a predictor of prognosis in patients following hepatectomy for hepatocellular carcinoma.

Authors:  N Harimoto; K Shirabe; Y-I Yamashita; T Ikegami; T Yoshizumi; Y Soejima; T Ikeda; Y Maehara; A Nishie; T Yamanaka
Journal:  Br J Surg       Date:  2013-10       Impact factor: 6.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.